Current PhD Students

Kerry is a PhD student in the Chronic Disease Epidemiology Department at the Yale School of Public Health. She holds an MSc in Health Data Science from the London School of Hygiene & Tropical Medicine and worked as a junior statistician at the Oxford Vaccine Group before coming to Yale. She is interested in using real-world data sources to explore treatment patterns and outcomes associated with emerging cancer therapies.

Meet Yale School of Public Health's Abigail Girgis.

Jiaqi Hu is a doctoral student at the Department of Chronic Disease Epidemiology, Yale School of Public Health. Having graduated from Peking University in 2021 with a Bachelor of Art degree, she continued to study and conduct research in genetic epidemiology. Her research interest is to identify genetic variants that increase risk for complicated diseases and combine genetic and environmental information to predict individual risk of disease.

Esther Kang is a PhD candidate in the Department of Chronic Disease Epidemiology with a primary focus on genetic epidemiology. She is a member of Dr. Andrew DeWan's lab in the Center for Perinatal, Pediatric and Environmental Epidemiology (CPPEE). Her current research investigates genetic contributions underlying fetal growth, anthropometric traits, cardio-metabolic outcomes, and other complex traits.

Yining Li is a doctoral student at the Department of Chronic Disease Epidemiology, Yale School of Public Health. She finished her undergraduate study at Peking University with a Bachelor of Medicine degree. She is currently interested in incorporating analytical methods to identify common variants related to different phenotypes, especially those in chronic non-communicable diseases.

Reed Mszar, MPH, MS, is a PhD student in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. His research encompasses cardiovascular and clinical epidemiology, health outcomes and disparities research, and cardio-oncology. Before returning to Yale, he worked in the Division of Clinical Effectiveness and Decision Science at the Patient-Centered Outcomes Research Institute (PCORI) where he supported the development of research funding announcements and managed a diverse portfolio of funded studies. Reed also conducted research at Yale's Center for Outcomes Research and Evaluation (CORE) leading projects focused on patient-reported outcomes and shared decision-making, subclinical atherosclerosis imaging, atrial fibrillation ablation disparities, and financial hardship from medical bills.

Katerina Santiago is a PhD student in the Department of Chronic Disease Epidemiology at Yale School of Public Health. She earned her Master of Public Health (MPH) from the University of Miami, Miller School of Medicine and her Bachelor of Science (BS) degree in Biology with Honors from the University of Miami. Prior to her doctoral studies, Katerina worked as a research associate at the University of Miami, Miller School of Medicine where her research focused on occupational exposures and their association with various health effects such as injuries and cancer and how such risks vary by race and ethnicity. Her current research interests are epidemiology of cancer, with a specific interest in gastrointestinal cancers, and how genetic risk interacts with environmental and occupational exposures.

Sunny Siddique is a doctoral candidate in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. He holds a Master of Public Health (MPH) in Epidemiology from Columbia University and a Bachelor of Arts (BA) in Molecular Biology from Princeton University. Prior to Yale, Sunny served as a Cancer Research Training Award Fellow at the National Cancer Institute where he studied age-related functional outcomes among cancer survivors, pain management among cancer patients visiting the ER, and follow-up and surveillance strategies to improve detection of cancer recurrence. Sunny has also conducted substantial work in analyzing cancer center catchment areas and identifying neighborhood level disparities in cancer treatment and outcomes. His current research interests include: risk factors and screening for early-onset gastrointestinal cancers (particularly colorectal, pancreas, stomach, and liver cancers), access and utilization of novel treatments, and the functional outcomes of long-term cancer survivors.